Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

5-HT4 agonists from Yoshitomi with broad therapeutic potential

July 18, 1997

RS-67506 enhances lower intestinal propulsion in mice

July 17, 1997

Fujisawa comarkets Hokuriku's Ganaton

July 16, 1997

Pharmacokinetics of nicotine carbomer enema evaluated in UC patients and volunteers

July 16, 1997

Dainippon presents promising antisecretory agent

July 15, 1997

BMS compound excellent candidate for development in HBV

July 14, 1997

Antiulcer drug shows bactericidal activity against H. pylori

July 14, 1997

Losec available in U.K. for symptoms of dyspepsia

July 9, 1997

Novopharm granted final approval by U.S. Federal Court to market generic Zantac

July 7, 1997

Genzyme and Massachusetts General Hospital to collaborate on gene therapy projects

July 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...